About Daniel Estandian
Form D filings for Glyphic Biotechnologies in 2024 list Daniel Estandian as executive officer and director.
Daniel Estandian first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Estandian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Estandian works with at each company, as listed on that company's latest Form D.
Glyphic Biotechnologies, Inc. · Form D, Feb 16, 2024